--- title: "Is Centerra Gold (TSX:CG) Undervalued On Its New Idaho Drill Campaign?" type: "News" locale: "en" url: "https://longbridge.com/en/news/291705252.md" description: "Centerra Gold (TSX:CG) initiated a ~3,000m drill program at Idaho's Crane Creek Project, funding up to US$1.7 million under an earn-in agreement. Trading at CA$24.41, the stock shows strong momentum with a 1-year return of 141.24%. Analysis suggests Centerra is undervalued, citing a fair value of CA$32.42 driven by growth pipelines like Mount Milligan and Goldfield, despite risks from grade variability and rising royalties." datetime: "2026-07-04T15:57:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291705252.md) - [en](https://longbridge.com/en/news/291705252.md) - [zh-HK](https://longbridge.com/zh-HK/news/291705252.md) generator: "portal-rs" --- # Is Centerra Gold (TSX:CG) Undervalued On Its New Idaho Drill Campaign? Centerra Gold (TSX:CG) has kicked off a roughly 3,000 metre drill program at Headwater Gold’s Crane Creek Project in Idaho, funding up to US$1.7 million under an existing earn-in agreement. See our latest analysis for Centerra Gold. At a share price of CA$24.41, Centerra Gold has seen a 1 day share price return of 3.96%, a year to date share price return of 25.70%, and a 1 year total shareholder return of 141.24%, signalling strong momentum after a recent period in which the 90 day share price return declined 4.12%. If this drilling update has you looking more broadly at gold producers, it could be a good time to scan other opportunities using our curated list of 33 elite gold producer stocks With Centerra Gold trading at CA$24.41 alongside an indicated intrinsic discount of about 16% and a sizeable gap to analyst targets, the key question is simple: is there still value on the table here, or is the market already pricing in future growth? ## Most Popular Narrative: 24.7% Undervalued The most followed valuation narrative for Centerra Gold pegs fair value at CA$32.42 versus the current CA$24.41, setting up a sizeable gap that hinges on long term cash flow assumptions. > *Centerra Gold's multi-year organic growth pipeline, including life extension and throughput expansion at Mount Milligan (PFS in Q3 2025), the low-capex Goldfield Project (first production targeted for 2028), and advanced studies at Kemess, is presented as positioning the company to offset reserve depletion and sustain or grow revenues in an environment of robust gold demand associated with macroeconomic uncertainty and strong central bank buying.* Read the complete narrative. Want to see what ties that project list to a higher fair value for Centerra Gold? Revenue trajectories, margin assumptions and a future earnings multiple all sit at the core of this narrative, but the exact mix of those levers is where the story gets interesting. **Result: Fair Value of CA$32.42 (UNDERVALUED)** Have a read of the narrative in full and understand what's behind the forecasts. However, this Centerra Gold narrative can still be knocked off course if Mount Milligan's grade variability weighs on production or if Oksüt's rising royalties squeeze margins. Find out about the key risks to this Centerra Gold narrative. ## Next Steps With Centerra Gold presenting both clear upside arguments and real concerns, it makes sense to move quickly, test the assumptions, and weigh the trade off between 4 key rewards and 2 important warning signs. ## Looking for more investment ideas beyond Centerra Gold? If Centerra Gold has sharpened your focus on opportunities, do not stop here. Use these targeted stock ideas to pressure test your thesis and spot what others might miss. - Zero in on quality at a discount by reviewing companies on our 7 high quality undervalued stocks that pair fundamentals with prices below their indicated worth. - Explore potential income streams by scanning our hand picked 6 dividend fortresses that focus on higher yields supported by underlying business strength. - Prioritise resilience by checking companies in the 11 resilient stocks with low risk scores that score well on balance sheet strength and risk indicators. *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.* ### **New:** AI Stock Screener & Alerts Our new AI Stock Screener scans the market every day to uncover opportunities. • Dividend Powerhouses (3%+ Yield) • Undervalued Small Caps with Insider Buying • High growth Tech and AI Companies Or build your own from over 50 metrics. Explore Now for Free ### Related Stocks - [CGAU.US](https://longbridge.com/en/quote/CGAU.US.md) ## Related News & Research - [Azimut Exploration closes $7 million private placement of flow-through, hard-dollar shares](https://longbridge.com/en/news/296266389.md) - [Centerra Gold buys 4,038,647 Azimut Exploration shares for C$2.42 million in private placement](https://longbridge.com/en/news/296479162.md) - [BioSyent GAAP EPS of C$0.25, revenue of C$19.87M](https://longbridge.com/en/news/296538491.md) - [Osisko Metals hits 313 m at 0.56% Cu in drilling at Gaspé copper project in Quebec](https://longbridge.com/en/news/296470204.md) - [IDEX Metals forms joint venture with WestGold on Idaho projects, retains 10% carried interest](https://longbridge.com/en/news/296225228.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**